Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial.
Pan J, Tan Y, Wang G, Deng B, Ling Z, Song W, Seery S, Zhang Y, Peng S, Xu J, Duan J, Wang Z, Yu X, Zheng Q, Xu X, Yuan Y, Yan F, Tian Z, Tang K, Zhang J, Chang AH, Feng X.
J Clin Oncol. 2021 Oct 20;39(30):3340-3351. doi: 10.1200/JCO.21.00389. Epub 2021 Jul 29.
Donor-Recipient Chimeric Cell Transplantation as the Bridging Therapy for Mitigating Total Body Irradiation-Induced Injury.
Siemionow M, Bieda K, Stawarz K, Cyran M, Chambily L, Kusza K.
Stem Cells Dev. 2024 Jul;33(13-14):343-354. doi: 10.1089/scd.2024.0068. Epub 2024 May 23.
Transplantation of Donor-Recipient Chimeric Cells Restores Peripheral Blood Cell Populations and Increases Survival after Total Body Irradiation-Induced Injury in a Rat Experimental Model.
Siemionow M, Cyran M, Stawarz K, Chambily L, Kusza K.
Arch Immunol Ther Exp (Warsz). 2024 May 23;72(1). doi: 10.2478/aite-2024-0009. eCollection 2024 Jan 1.
Stem cell engraftment strategies.
Quesenberry PJ, Stewart FM, Becker P, D'Hondt L, Frimberger A, Lambert JF, Colvin GA, Miller C, Heyes C, Abedi M, Dooner M, Carlson J, Reilly J, McAuliffe C, Stencel K, Ballen K, Emmons R, Doyle P, Zhong S, Wang H, Habibian H.
Ann N Y Acad Sci. 2001 Jun;938:54-61; discussion 61-2. doi: 10.1111/j.1749-6632.2001.tb03574.x.
Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells.
Verdonck LF, van Blokland WT, Bosboom-Kalsbeek EK, van Heugten HG, Tilanus MG, de Weger RA.
Bone Marrow Transplant. 1996 Aug;18(2):389-95.
Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failure.
Mohamedbhai SG, Edwards N, Morris EC, Mackinnon S, Thomson KJ, Peggs KS.
Br J Haematol. 2012 Feb;156(4):516-22. doi: 10.1111/j.1365-2141.2011.08944.x. Epub 2011 Dec 15.
iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model.
Ishii R, Hirai T, Miyairi S, Omoto K, Okumi M, Ishii Y, Tanabe K.
Am J Transplant. 2018 Feb;18(2):328-340. doi: 10.1111/ajt.14453. Epub 2017 Sep 15.
Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.
Hayashi S, Peranteau WH, Shaaban AF, Flake AW.
Blood. 2002 Aug 1;100(3):804-12. doi: 10.1182/blood-2002-01-0016.
Donor T-cell and myeloid chimerism is higher after cord blood transplant than with other cell sources.
Nadaf R, Lee H, Mustafa O, Bonney D, Mirci-Danicar O, Hanasoge-Nataraj R, Senthil S, Horgan C, Logan A, Poulton K, Wynn R.
Cytotherapy. 2025 Nov;27(11):1338-1343. doi: 10.1016/j.jcyt.2025.07.003. Epub 2025 Jul 18.
Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
Peterlin P, Delaunay J, Guillaume T, Gastinne T, Mahé B, Dubruille V, Blin N, Le Bourgeois A, Brissot E, Lodé L, Le Gouill S, Moreau P, Mohty M, Chevallier P.
Biol Blood Marrow Transplant. 2015 Jan;21(1):180-4. doi: 10.1016/j.bbmt.2014.08.018. Epub 2014 Aug 28.
